13 years 🥳 of Publication, 100k+ Stories, 30+ Countries
Search
Latham Advises Chandra Asri on Acquisition of Shell’s Energy and Chemicals Assets in Singapore
Latham & Watkins has advised PT Chandra Asri Pacific Tbk (Chandra Asri), Indonesia's leading chemical and infrastructure solutions company, on…
Latham & Watkins Advises Allogene Therapeutics in Pricing of US$110 Million Offering of Common Stock
Firm represents the sole book-running manager in the offering. Allogene Therapeutics, Inc. (Nasdaq: ALLO), a clinical-stage biotechnology company pioneering the…
Latham & Watkins Advises Erasca on Underwritten Offering of Common Stock
Erasca, Inc. (Nasdaq: ERAS), a clinical-stage precision oncology company singularly focused on discovering, developing, and commercializing therapies for patients with…
Latham & Watkins Advises on Insight Enterprises, Inc.’s US$500 Million Senior Notes Offering
Insight Enterprises, Inc. (NASDAQ: NSIT), a global Fortune 500 Solutions Integrator helping accelerate transformation by unlocking the power of people…
Latham Advises Cogent in Cross-Border IPv4 Address Securitization
Cogent Communications Holdings, Inc. (NASDAQ:CCOI) (Cogent), a leading internet service provider with operations in 53 countries across North America, Europe,…
Latham & Watkins Advises Eni S.p.A. on its US$2.25 Billion US Bond Issuance
Latham & Watkins has advised Eni in its successful issuance of a dual tranche fixed rate bond in the US…
